Drugs / FLU-v
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01226758 | Jun → Dec 2010 | influenza | PepTcell Limited | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLU-v | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01226758 ↗ |
| Modality | Vaccine | “a vaccine candidate (FLU-v) eliciting cellular immunity.” PMID 25994549 ↗ May 2015 |
| Route | Subcutaneous | “Administered by single subcutaneous injection.” NCT01226758 ↗ |